Literature DB >> 2458048

Subcutaneous sacrococcygeal ("myxopapillary") ependymal rests.

D R Pulitzer1, P C Martin, P C Collins, D R Ralph.   

Abstract

Ependymal cell rests of the sacrococcygeal area are relatively common; they may occur in association with postcoccygeal (pilonidal) dimples or in the absence of observable abnormalities. Some of the lesions are poorly organized, whereas others closely resemble minute myxopapillary ependymomas. Most authorities believe that the majority of subcutaneous sacrococcygeal myxopapillary ependymomas arise in ependymal cell rests. Myxopapillary ependymomas may be locally aggressive and may metastasize, whereas ependymal rests are biologically indolent. We studied cutaneous ependymal rests of the sacrococcygeal region in four children to compare them with myxopapillary ependymomas of this anatomic site. All lesions were small (less than 0.5 cm) and were discovered incidentally in tissue from surgically corrected pilonidal sinuses. In no case was a mass lesion observed either clinically or upon gross examination of the excised specimen. Microscopically, the lesions consisted of clusters of ependymal cells near the junction of dermis and subcutis. Central vascular channels were surrounded by myxomatous material and rows of cuboidal cells, mimicking patterns seen in myxopapillary ependymomas. They differed from ependymomas in that they lacked characteristics associated with neoplasia--expansile, infiltrative, and destructive properties. Careful attention to histologic detail allows distinction of these lesions, which, though related, differ significantly in terms of prognosis.

Entities:  

Mesh:

Year:  1988        PMID: 2458048     DOI: 10.1097/00000478-198809000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  9 in total

1.  Myxopapillary ependymomas arising from nerve roots of the spinal cord.

Authors:  A Sharma
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-06       Impact factor: 10.154

2.  A Rare Case of Metastatic Primary Peritoneal Ependymoma: A Case Report and Literature Review.

Authors:  Ben Man Fei Cheung; Johnny Kin Sang Lau; Anthony W I Lo; Mai-Yee Luk; Kwok Keung Yuen
Journal:  Case Rep Oncol Med       Date:  2020-08-14

Review 3.  Pediatric extraspinal sacrococcygeal ependymoma (ESE): an Italian AIEOP experience of six cases and literature review.

Authors:  Elisabetta Schiavello; Veronica Biassoni; Manila Antonelli; Piergiorgio Modena; Simone Cesaro; Paolo Pierani; Lorenza Gandola
Journal:  Childs Nerv Syst       Date:  2018-05-03       Impact factor: 1.475

4.  Intrasacral myxopapillary ependymoma.

Authors:  L E Ginsberg; D W Williams; C Stanton
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

5.  Long term outcomes following surgical resection of myxopapillary ependymomas.

Authors:  Carlos A Bagley; Sean Wilson; Karl F Kothbauer; Markus J Bookland; Fred Epstein; George I Jallo
Journal:  Neurosurg Rev       Date:  2009-02-17       Impact factor: 3.042

6.  Myxopapillary ependymoma as a cause of back pain in a young male - A case report.

Authors:  Trung P Ngo; John Dufton; Paula J Stern; Omar Islam
Journal:  J Can Chiropr Assoc       Date:  2013-06

7.  Grade III intradural extramedullary anaplastic ependymoma managed with near-complete resection and adjuvant radiotherapy: a case report.

Authors:  Satoshi Ando; Osahiko Tsuji; Narihito Nagoshi; Satoshi Nori; Satoshi Suzuki; Eijiro Okada; Mitsuru Yagi; Rie Irie; Kota Watanabe; Masaya Nakamura; Morio Matsumoto
Journal:  Spinal Cord Ser Cases       Date:  2021-01-19

8.  Recurrent Extradural Myxopapillary Ependymoma With Oligometastatic Spread.

Authors:  Kristen A Batich; Richard F Riedel; John P Kirkpatrick; Betty C Tong; William C Eward; Char Loo Tan; Patricia D Pittman; Roger E McLendon; Katherine B Peters
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

9.  Pediatric Spinal Ependymomas.

Authors:  Özden Erhan Sofuoğlu; Anas Abdallah
Journal:  Med Sci Monit       Date:  2018-10-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.